Anlotinib hydrochloride
KY-20231219001-01
Unknown small_molecule active
Quick answer
Anlotinib hydrochloride for Non-Small-Cell Lung Cancer is a Unknown program (small_molecule) at First Tracks Biotherapeutics with 2 ClinicalTrials.gov record(s).
Program details
- Company
- First Tracks Biotherapeutics
- Indication
- Non-Small-Cell Lung Cancer
- Phase
- Unknown
- Modality
- small_molecule
- Status
- active